Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder

Overview of attention for article published in Addiction Science & Clinical Practice, February 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 32 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 40 X posts from 32 X users, with an upper bound of 52,158 followers.

RT @especially_APT: @makarov__ You might be thinking of the SALOME study? https://t.co/uUF6x2vRmX And yes! Many of us are starting to inte…

07 Dec 2023

Reply Repost Favourite

@makarov__ You might be thinking of the SALOME study? https://t.co/uUF6x2vRmX And yes! Many of us are starting to integrate hydromorphone into withdrawal management (eg: https://t.co/bBDvElH5dW) but a lot more work needed to protocolize this approach

07 Dec 2023

Reply Repost Favourite

@lukesjulson @GraceKoopermd @clairezagorski @BrooksWalsh @RyanMarino Can be effective depending on the setting! https://t.co/r8pc9FcmI6

24 Nov 2023

Reply Repost Favourite

21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder. Addict Sci Clin Pract 18, 13 (2023). https://t.co/4

25 Oct 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 36 additional X posts.